Smith & Nephew plc (FRA:NPWA)

Market Cap	13.01B +23.4%
Revenue (ttm)	5.07B +5.4%
Net Income	419.07M +61.0%
EPS	0.48 +59.9%
Shares Out	n/a
PE Ratio	31.04
Forward PE	16.39
Dividend	0.66 (2.16%)
Ex-Dividend Date	Oct 3, 2025

Volume	n/a
Average Volume	n/a
Open	30.40
Previous Close	30.60
Day's Range	30.40 - 30.40
52-Week Range	22.40 - 33.00
Beta	n/a
RSI	60.04
Earnings Date	Mar 2, 2026

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. It operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction proced...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1856
• Employees: 17,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: NPWA

Financial Performance

In 2024, Smith & Nephew's revenue was $5.81 billion, an increase of 4.70% compared to the previous year's $5.55 billion. Earnings were $412.00 million, an increase of 56.65%.

Financial numbers in USD